{
    "nctId": "NCT02897700",
    "briefTitle": "A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast",
    "officialTitle": "A Phase I Multi-Center Study to Evaluate the Safety, Tolerability, and Efficacy of Chemotherapeutic Regiments in Surgical Patients With Infiltrating Ductal Carcinoma of Breast",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Incidence of treatment-emergent adverse events",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients \u2265 18 years of age with histologically proven infiltrating ductal carcinoma of breast\n* no severe major organ dysfunction\n* Patients must have adequate hematopoietic function as evidenced by:\n\nwhite blood cells (WBC) \u2265 3,000/\u03bcl absolute neutrophil count (ANC) \u2265 1,500/\u03bcl Platelet count \u2265 100,000/\u03bcl hemoglobin (HGB) \u2265 10 g/dl and not transfusion dependent\n\n* Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) \u2264 10% above upper limit of normal\n* Individuals of child-bearing potential must have a negative serum or urine pregnancy test within 72 hours of Cycle 1 Day 1.\n* World Health Organization (WHO) performance status of 0 or 1\n* No prior or concurrent cancer-associated chemotherapy, no initiation of new hormonal therapy\n* Hormone receptor (estrogen receptor (ER), progesterone receptor (PR), epidermal growth factor receptor 2 (Her2)) status not specified\n* Menopausal status not specified\n* Patients or their legal representatives must be willing and able to provide written informed consent\n* A Clinical Stage \u2265 I subtype A (IA) (T1a, N0, M0) of Beast Cancer but without diagnosed distant metastasis (according to the 1997 revision of the International Union Against Cancer-PrimaryTumor, Regional Nodes and Metastasis (TNM) staging system) as determined by a preoperative evaluation that included a chest computed tomography (CT) scan and/or X-ray mammography.\n\nExclusion Criteria:\n\n* Age \\< 18\n* Severe major organ dysfunction\n* WHO performance status of \\>1\n* Prior cancer chemotherapy\n* Stage IV\n* Patients with symptomatic central nervous system (CNS) metastases from breast cancer\n* Patients with a history of another invasive malignancy within the last 3 years\n* History of loss of consciousness or transient ischemic attack within 12 months before study treatment initiation.\n* Patients who have known active HIV, Hepatitis B, or Hepatitis C infections.\n* Patients with any other condition which in the opinion of the investigator would preclude participation in the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}